# Fervo Energy Co: financial statements, quarterly

FRVO · Nasdaq · CIK 1853868 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frvo.md) · [Financials](/companies/frvo/financials.md) · [Filings](/companies/frvo/filings.md) · [Insiders](/companies/frvo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frvo/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001628280-26-044799.md) | [0.0](/filings/0001628280-26-056457.md) | [0.1](/filings/0001628280-26-044799.md) | [0.1](/filings/0001628280-26-056457.md) |
| Cost of revenue | $m | [0.3](/filings/0001628280-26-044799.md) | [0.2](/filings/0001628280-26-056457.md) | [0.5](/filings/0001628280-26-044799.md) | [0.3](/filings/0001628280-26-056457.md) |
| Operating income | $m | [(9.9)](/filings/0001628280-26-044799.md) | [(10.3)](/filings/0001628280-26-056457.md) | [(20.1)](/filings/0001628280-26-044799.md) | [(28.7)](/filings/0001628280-26-056457.md) |
| Interest expense | $m | [1.2](/filings/0001628280-26-044799.md) | [1.7](/filings/0001628280-26-056457.md) | [2.7](/filings/0001628280-26-044799.md) | [2.2](/filings/0001628280-26-056457.md) |
| Income tax | $m | not reported | [0.0](/filings/0001628280-26-056457.md) | not reported | [0.0](/filings/0001628280-26-056457.md) |
| Net income | $m | [(9.1)](/filings/0001628280-26-056457.md) | [(11.4)](/filings/0001628280-26-056457.md) | [(31.8)](/filings/0001628280-26-056457.md) | [(55.9)](/filings/0001628280-26-056457.md) |
| Diluted EPS | $ per share | [(1.02)](/filings/0001628280-26-044799.md) | [(1.31)](/filings/0001628280-26-056457.md) | [(3.72)](/filings/0001628280-26-044799.md) | [(0.38)](/filings/0001628280-26-056457.md) |
| Basic EPS | $ per share | [(1.02)](/filings/0001628280-26-044799.md) | [(1.31)](/filings/0001628280-26-056457.md) | [(3.72)](/filings/0001628280-26-044799.md) | [(0.38)](/filings/0001628280-26-056457.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [462](/filings/0001628280-26-056457.md) | [281](/filings/0001628280-26-044799.md) | [2,106](/filings/0001628280-26-056457.md) |
| Current assets | $m | not reported | not reported | not reported | [482](/filings/0001628280-26-056457.md) | [308](/filings/0001628280-26-044799.md) | [2,154](/filings/0001628280-26-056457.md) |
| Total assets | $m | not reported | not reported | not reported | [1,365](/filings/0001628280-26-056457.md) | [1,428](/filings/0001628280-26-044799.md) | [3,535](/filings/0001628280-26-056457.md) |
| Current liabilities | $m | not reported | not reported | not reported | [152](/filings/0001628280-26-056457.md) | [202](/filings/0001628280-26-044799.md) | [250](/filings/0001628280-26-056457.md) |
| Total liabilities | $m | not reported | not reported | not reported | [409](/filings/0001628280-26-056457.md) | [500](/filings/0001628280-26-044799.md) | [554](/filings/0001628280-26-056457.md) |
| Long-term debt | $m | not reported | not reported | not reported | [173](/filings/0001628280-26-056457.md) | [187](/filings/0001628280-26-044799.md) | [217](/filings/0001628280-26-056457.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-26-056457.md) | not reported | [11.0](/filings/0001628280-26-056457.md) |
| Shareholders' equity | $m | [(177)](/filings/0001628280-26-056457.md) | [(188)](/filings/0001628280-26-056457.md) | [(198)](/filings/0001628280-26-056457.md) | [(246)](/filings/0001628280-26-056457.md) | [(278)](/filings/0001628280-26-056457.md) | [2,794](/filings/0001628280-26-056457.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.1](/filings/0001628280-26-044799.md) | [(10.9) d](/filings/0001628280-26-056457.md) | [(9.0)](/filings/0001628280-26-044799.md) | [(34.7) d](/filings/0001628280-26-056457.md) |
| Capital expenditure | $m | [105](/filings/0001628280-26-044799.md) | [108 d](/filings/0001628280-26-056457.md) | [173](/filings/0001628280-26-044799.md) | [226 d](/filings/0001628280-26-056457.md) |
| Share repurchases | $m | [1.9](/filings/0001628280-26-044799.md) | [0.0 d](/filings/0001628280-26-056457.md) | [0.0](/filings/0001628280-26-044799.md) | [0.0 d](/filings/0001628280-26-056457.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.0](/filings/0001628280-26-044799.md) | [8.8](/filings/0001628280-26-056457.md) | [9.5](/filings/0001628280-26-044799.md) | [157](/filings/0001628280-26-056457.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.